Zelira Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Operating Revenue	0	0.09	0.3	1.54	0.66	Upgrade
Revenue	0	0.09	0.3	1.54	0.66	Upgrade
Revenue Growth (YoY)	-99.31%	-68.47%	-80.45%	132.26%	-	Upgrade
Cost of Revenue	0.8	0.33	0.63	0.94	0.23	Upgrade
Gross Profit	-0.8	-0.23	-0.33	0.6	0.44	Upgrade
Selling, General & Admin	1.67	2.33	5.89	7.39	5.85	Upgrade
Research & Development	2.66	2.81	1.34	1.4	2.08	Upgrade
Other Operating Expenses	0.1	0.01	0.12	0.23	0.11	Upgrade
Operating Expenses	3.52	5.66	6.84	13.81	9.82	Upgrade
Operating Income	-4.32	-5.9	-7.16	-13.21	-9.38	Upgrade
Interest Expense	-0.41	-0.74	-0.08	-0.05	-0.04	Upgrade
Interest & Investment Income	-	0	0	0.01	0	Upgrade
Other Non Operating Income (Expenses)	0.88	0.64	1.03	0.9	1.05	Upgrade
EBT Excluding Unusual Items	-3.85	-5.99	-6.21	-12.35	-8.37	Upgrade
Impairment of Goodwill	-	-30.75	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	-	-	-0.06	-0.07	-0.18	Upgrade
Pretax Income	-3.85	-36.74	-6.27	-12.41	-8.55	Upgrade
Earnings From Continuing Operations	-3.85	-36.74	-6.27	-12.41	-8.55	Upgrade
Minority Interest in Earnings	0.22	0.17	0.7	0.47	-	Upgrade
Net Income	-3.63	-36.57	-5.57	-11.95	-8.55	Upgrade
Net Income to Common	-3.63	-36.57	-5.57	-11.95	-8.55	Upgrade
Shares Outstanding (Basic)	11	11	10	8	7	Upgrade
Shares Outstanding (Diluted)	11	11	10	8	7	Upgrade
Shares Change (YoY)	1.20%	12.70%	25.19%	21.25%	36.81%	Upgrade
EPS (Basic)	-0.32	-3.22	-0.55	-1.49	-1.29	Upgrade
EPS (Diluted)	-0.32	-3.22	-0.55	-1.49	-1.29	Upgrade
Free Cash Flow	-4.91	-4.39	-7.25	-9.43	-8.62	Upgrade
Free Cash Flow Per Share	-0.43	-0.39	-0.72	-1.17	-1.30	Upgrade
Gross Margin	-	-246.37%	-108.91%	39.05%	65.59%	Upgrade
Operating Margin	-658713.11%	-6211.63%	-2379.17%	-857.21%	-1414.10%	Upgrade
Profit Margin	-553029.27%	-38513.04%	-1850.75%	-775.36%	-1288.84%	Upgrade
Free Cash Flow Margin	-747996.04%	-4621.90%	-2407.36%	-611.91%	-1299.02%	Upgrade
EBITDA	-4.17	-5.54	-6.74	-12.73	-9.02	Upgrade
D&A For EBITDA	0.15	0.35	0.42	0.47	0.36	Upgrade
EBIT	-4.32	-5.9	-7.16	-13.21	-9.38	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.